Gofen & Glossberg LLC Amgen Inc Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Amgen Inc stock. As of the latest transaction made, Gofen & Glossberg LLC holds 25,188 shares of AMGN stock, worth $7.42 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

25,188

Previous 24,808 1.53%

Holding current value

$7.42 Million

Previous $5.59 Million 18.29%

% of portfolio

0.17%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$229.03 - $291.01 $87,031 - $110,583	380 Added 1.53%	25,188 $6.62 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $12,794 - $14,429	57 Added 0.23%	24,808 $5.59 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $32,068 - $35,686	-139 Reduced 0.56%	24,751 $6.02 Million
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $155,023 - $171,496	-707 Reduced 2.76%	24,890 $6.02 Million
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $79,750 - $91,267	-401 Reduced 1.54%	25,597 $5.76 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $57,100 - $66,900	269 Added 1.05%	25,998 $5.53 Million
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $15,649 - $17,362	67 Added 0.26%	25,729 $6.27 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $190,842 - $222,396	860 Added 3.47%	25,662 $6.39 Million
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $216 - $257	1 Added 0.0%	24,802 $5.7 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $60,774 - $67,586	-259 Reduced 1.03%	24,801 $6.3 Million
Q2 2020 Jul 13, 2020	BUY	$197.81 - $242.74 $812,010 - $996,447	4,105 Added 19.59%	25,060 $5.91 Million
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $41,004 - $54,382	225 Added 1.09%	20,955 $4.25 Million
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $48,059 - $61,772	254 Added 1.24%	20,730 $5 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $133,716 - $160,220	768 Added 3.9%	20,476 $3.96 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $110,855 - $129,947	665 Added 3.49%	19,708 $3.63 Million
Q1 2019 Apr 11, 2019	SELL	$180.87 - $203.88 $1,808 - $2,038	-10 Reduced 0.05%	19,043 $3.62 Million
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $160,203 - $187,008	-898 Reduced 4.5%	19,053 $3.71 Million
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $55,216 - $62,249	298 Added 1.52%	19,951 $4.14 Million
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $72,231 - $81,131	-435 Reduced 2.17%	19,653 $3.63 Million
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 0.12%	20,088 $3.43 Million
Q4 2017 Jan 11, 2018	BUY	$168.79 - $188.59 $15,191 - $16,973	90 Added 0.45%	20,113 $3.5 Million
Q3 2017 Nov 16, 2017	SELL	$167.29 - $191.0 $8,364 - $9,550	-50 Reduced 0.25%	20,023 $3.73 Million
Q2 2017 Aug 16, 2017	BUY	N/A	20,073	20,073 $3.46 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Amgen Inc Transaction History